Multi-component cortical peptide mixture with neurotrophic, neuroprotective, and nootropic activity. Activates BDNF and NGF pathways. Reduces neuronal apoptosis via Bcl-2 upregulation. Modulates brain metabolism and neurotransmitter balance. Similar mechanism class to cerebrolysin but specific to cortical peptide fractions.
Studies have administered: 10mg/day IM for 10 days in published Russian/Eastern European trials
Russian pediatric neurology: improved cognitive metrics in children with developmental delays. Stroke rehabilitation: functional improvement over rehabilitation alone in multiple studies. Neonatal hypoxia-ischemia: reduced long-term deficits in animal models. Limited Western peer-review.
Animal-derived product — allergy consideration; generally well-tolerated per published literature; limited independent replication
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Cortexin — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat